Product Information

FLUTICASONE-SALMETEROL 55-14 is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $113.7872 per EA under NDC 00093360782. Its NADAC has been published 436 times since Apr 18, 2018.

FDA first approved this application on Jan 27, 2017.

FLUTICASONE-SALMETEROL 55-14

Fluticasone Propionate and Salmeterol
$113.7872per EA

Strength

55; 14 ug/1; ug/1

NDC

00093360782

Classification

Generic

Dosage Form

POWDER, METERED

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA208799

FDA Approved

1/27/2017

On Market Since

4/28/2017

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price Statistics

The NADAC for FLUTICASONE-SALMETEROL 55-14 has been published 436 times since Apr 18, 2018, and over the history we have for it it has risen 25.8%. The table below summarizes its recorded NADAC range and movement.

Current price$113.7872 per EA
All-time high$113.7872 (Aug 19, 2026)
All-time low$83.3740 (Jan 23, 2019)
52-week high$113.7872
52-week low$108.1785
Median price$99.4669
Average price$98.0233
Largest weekly change+21.0% (Apr 20, 2022)
Weeks tracked436
Tracking sinceApr 18, 2018

Price History

1W

+1.3%

1M

+1.3%

3M

+3.2%

6M

+4.6%

1Y

+4.8%

3Y

+9.0%

5Y

+30.4%

All

+25.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fluticasone Propionate and Salmeterol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of FLUTICASONE-SALMETEROL 55-14?

The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE-SALMETEROL 55-14, manufactured by Teva Pharmaceuticals USA Inc., is $113.7872 per EA (NDC 00093360782), effective Aug 19, 2026.

How has the price of FLUTICASONE-SALMETEROL 55-14 changed over time?

Over the history we have for it, the NADAC for FLUTICASONE-SALMETEROL 55-14 has risen 25.8%. It has been tracked across 436 weekly CMS publications since Apr 18, 2018.

What are the highest and lowest recorded NADAC prices for FLUTICASONE-SALMETEROL 55-14?

Since Apr 18, 2018, the NADAC for FLUTICASONE-SALMETEROL 55-14 has ranged from a low of $83.3740 (Jan 23, 2019) to a high of $113.7872 (Aug 19, 2026), with a median of $99.4669 per EA.

Are there cheaper alternatives to FLUTICASONE-SALMETEROL 55-14?

No other NADAC-published product currently shares the active ingredient and strength of FLUTICASONE-SALMETEROL 55-14 in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures FLUTICASONE-SALMETEROL 55-14?

FLUTICASONE-SALMETEROL 55-14 (NDC 00093360782) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.